SAN DIEGO - Contineum Therapeutics, Inc. (NASDAQ:CTNM) announced Thursday that its Phase 2 VISTA trial for PIPE-307, an M1 receptor antagonist being developed for relapsing-remitting multiple ...

During NewsMatch 2025, your donation is doubled to help keep our data and reporting available to the public. Give today and power the facts that strengthen democracy.

Selecting the right web host is essential for online success. The best web hosting services we've tested cater to a wide range of users, from small bloggers to big businesses, and everything in ...

WhatsApp is testing a new feature that allows iPhone users to manage two separate accounts within the same app, according to WABetaInfo. As found in the latest TestFlight beta on iOS, the feature ...

SHANGHAI, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the ...

SAN FRANCISCO and SUZHOU, China, Nov. 19, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...